Li Ye, Miao Xiaoqing, Chen Tongkai, Yi Xiang, Wang Ruibing, Zhao Haitao, Lee Simon Ming-Yuen, Wang Xueqing, Zheng Ying
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27516, United States.
Colloids Surf B Biointerfaces. 2017 Aug 1;156:227-235. doi: 10.1016/j.colsurfb.2017.05.022. Epub 2017 May 10.
With the wide application of nanotechnology to drug delivery systems, a simple, dynamic and visual in vivo model for high-throughput screening of novel formulations with fluorescence markers across biological barriers is desperately needed. In vitro cell culture models have been widely used, although they are far from a complimentary in vivo system. Mammalian animal models are common predictive models to study transport, but they are costly and time consuming. Zebrafish (Danio rerio), a small vertebrate model, have the potential to be developed as an "intermediate" model for quick evaluations. Based on our previously established coumarin 6 nanocrystals (C6-NCs), which have two different sizes, the present study investigates the transportation of C6-NCs across four biological barriers, including the chorion, blood brain barrier (BBB), blood retinal barrier (BRB) and gastrointestinal (GI) barrier, using zebrafish embryos and larvae as in vivo models. The biodistribution and elimination of C6 from different organs were quantified in adult zebrafish. The results showed that compared to 200nm C6-NCs, 70nm C6-NCs showed better permeability across these biological barriers. A FRET study suggested that intact C6-NCs together with the free dissolved form of C6 were absorbed into the larval zebrafish. More C6 was accumulated in different organs after incubation with small sized NCs via lipid raft-mediated endocytosis in adult zebrafish, which is consistent with the findings from in vitro cell monolayers and the zebrafish larvae model. C6-NCs could be gradually eliminated in each organ over time. This study demonstrated the successful application of zebrafish as a simple and dynamic model to simultaneously assess the transport of nanosized drug delivery systems across several biological barriers and biodistribution in different organs, especially in the brain, which could be used for central nervous system (CNS) drug and delivery system screening.
随着纳米技术在药物递送系统中的广泛应用,迫切需要一种简单、动态且可视化的体内模型,用于高通量筛选带有荧光标记的新型制剂跨越生物屏障的情况。体外细胞培养模型已被广泛使用,尽管它们远非互补的体内系统。哺乳动物动物模型是研究转运的常见预测模型,但它们成本高且耗时。斑马鱼(Danio rerio)作为一种小型脊椎动物模型,有潜力被开发为用于快速评估的“中间”模型。基于我们先前制备的具有两种不同尺寸的香豆素6纳米晶体(C6-NCs),本研究以斑马鱼胚胎和幼虫作为体内模型,研究了C6-NCs跨越四种生物屏障的运输情况,这四种生物屏障包括卵膜、血脑屏障(BBB)、血视网膜屏障(BRB)和胃肠道(GI)屏障。在成年斑马鱼中对不同器官中C6的生物分布和消除情况进行了定量。结果表明,与200nm的C6-NCs相比,70nm的C6-NCs在这些生物屏障上表现出更好的渗透性。一项荧光共振能量转移(FRET)研究表明,完整的C6-NCs以及C6的游离溶解形式被吸收到斑马鱼幼虫体内。在成年斑马鱼中,与小尺寸纳米晶体孵育后,更多的C6通过脂筏介导的内吞作用在不同器官中积累,这与体外细胞单层和斑马鱼幼虫模型的研究结果一致。随着时间的推移,C6-NCs可以在每个器官中逐渐消除。本研究证明了斑马鱼作为一种简单且动态的模型成功应用于同时评估纳米级药物递送系统跨越多种生物屏障的运输情况以及在不同器官尤其是大脑中的生物分布,可用于中枢神经系统(CNS)药物和递送系统的筛选。